Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells.

Magalhães AC, Baron GS, Lee KS, Steele-Mortimer O, Dorward D, Prado MA, Caughey B.

J Neurosci. 2005 May 25;25(21):5207-16.

2.

The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.

Pimpinelli F, Lehmann S, Maridonneau-Parini I.

Eur J Neurosci. 2005 Apr;21(8):2063-72.

PMID:
15869502
3.
4.

Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.

Akasaka K, Maeno A, Murayama T, Tachibana H, Fujita Y, Yamanaka H, Nishida N, Atarashi R.

Prion. 2014;8(4):314-8. doi: 10.4161/pri.32081.

6.

Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.

Vorberg I, Raines A, Priola SA.

J Biol Chem. 2004 Jul 9;279(28):29218-25. Epub 2004 May 7.

7.

Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.

Yamasaki T, Baron GS, Suzuki A, Hasebe R, Horiuchi M.

Virology. 2014 Feb;450-451:324-35. doi: 10.1016/j.virol.2013.11.007. Epub 2014 Jan 15.

8.

Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.

Cordes H, Bergström AL, Ohm J, Laursen H, Heegaard PM.

J Immunol Methods. 2008 Sep 15;337(2):106-20. doi: 10.1016/j.jim.2008.07.004. Epub 2008 Jul 25.

PMID:
18657541
9.

Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.

Shim SY, Karri S, Law S, Schatzl HM, Gilch S.

Sci Rep. 2016 Feb 11;6:21658. doi: 10.1038/srep21658.

11.

Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation.

Gilch S, Bach C, Lutzny G, Vorberg I, Schätzl HM.

Cell Mol Life Sci. 2009 Dec;66(24):3979-91. doi: 10.1007/s00018-009-0158-4. Epub 2009 Oct 13.

12.

Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent.

Greil CS, Vorberg IM, Ward AE, Meade-White KD, Harris DA, Priola SA.

Virology. 2008 Sep 30;379(2):284-93. doi: 10.1016/j.virol.2008.07.006. Epub 2008 Aug 8.

13.

Prion aggregates transfer through tunneling nanotubes in endocytic vesicles.

Zhu S, Victoria GS, Marzo L, Ghosh R, Zurzolo C.

Prion. 2015;9(2):125-35. doi: 10.1080/19336896.2015.1025189.

14.

Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts.

Russelakis-Carneiro M, Hetz C, Maundrell K, Soto C.

Am J Pathol. 2004 Nov;165(5):1839-48.

15.

A novel generation of heparan sulfate mimetics for the treatment of prion diseases.

Adjou KT, Simoneau S, Salès N, Lamoury F, Dormont D, Papy-Garcia D, Barritault D, Deslys JP, Lasmézas CI.

J Gen Virol. 2003 Sep;84(Pt 9):2595-603.

PMID:
12917481
16.
17.

Characterization of the role of dendritic cells in prion transfer to primary neurons.

Langevin C, Gousset K, Costanzo M, Richard-Le Goff O, Zurzolo C.

Biochem J. 2010 Oct 15;431(2):189-98. doi: 10.1042/BJ20100698.

18.

Molecular analysis of the protease-resistant prion protein in scrapie and bovine spongiform encephalopathy transmitted to ovine transgenic and wild-type mice.

Baron T, Crozet C, Biacabe AG, Philippe S, Verchere J, Bencsik A, Madec JY, Calavas D, Samarut J.

J Virol. 2004 Jun;78(12):6243-51.

19.
20.

Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.

Jeffrey M, McGovern G, Sisó S, González L.

Acta Neuropathol. 2011 Jan;121(1):113-34. doi: 10.1007/s00401-010-0700-3. Epub 2010 Jun 8. Review.

PMID:
20532540

Supplemental Content

Support Center